08.12.2012 Views

MALARIA ELIMINATION IN ZANZIBAR - Soper Strategies

MALARIA ELIMINATION IN ZANZIBAR - Soper Strategies

MALARIA ELIMINATION IN ZANZIBAR - Soper Strategies

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

As discussed, private facilities that will be allowed to treat malaria<br />

will need to be included in the surveillance and supervision<br />

system. Appropriate training of health workers in the private<br />

sector combined with aggressive IEC/BCC campaigns both<br />

targeting the patient and the health worker should also be a<br />

core component of case management efforts in an elimination<br />

program. Quality of care is difficult to assess, but it will be<br />

important that a number of relevant metrics be established and<br />

regularly monitored to ensure that the private sector is meeting<br />

the necessary standards for elimination.<br />

Diagnosis<br />

The current target of having 90% of all malaria cases seen in<br />

health facilities to be microscopy or RDT confirmed by 2014<br />

is sufficient for a control program (GFATM Malaria Proposal<br />

for Round 8), but a more ambitious–and challenging–target will<br />

need to be established as an elimination progresses. Specifically,<br />

100% of malaria cases seen in both public and private health<br />

facilities will need to be confirmed by RDT and/or microscopy.<br />

Adopting and implementing an appropriate algorithm for malaria<br />

diagnosis, including the use of different tools within the system,<br />

will be central to achieving that target. Given the current state of<br />

the health system and workforce, we recommend the following<br />

algorithm (see Table 13):<br />

1. All fever cases, regardless of the facility where they present,<br />

should be tested using an RDT.<br />

52<br />

2. All positive RDTs should be tested by polymerase chain<br />

reaction (PCR) at the central level.<br />

3. A 10% random sample of all negative RDTs should be tested<br />

by PCR for quality control.<br />

4. Where microscopy is available, all patients with a positive<br />

RDT should be re-tested at the facility using microscopy<br />

on both thick and thin films for species identification and<br />

parasite density quantification.<br />

5. All positive slides should be re-read for quality control at the<br />

central level.<br />

6. All negative slides (discordant results) will have to be re-read<br />

for quality control, the result should be compared to the<br />

PCR testing on the initial RDT taken (which indicated a<br />

positive result) and, if possible, the patient should be traced<br />

and tested again with PCR using a new sample. It will be<br />

very important to document these discordant results and to<br />

investigate the causes of the conflicting results.<br />

FIGURE 23: ALGORITHM FOR <strong>MALARIA</strong> TEST<strong>IN</strong>G <strong>IN</strong> AN <strong>ELIM<strong>IN</strong>ATION</strong><br />

PROGRAM<br />

Although the WHO guidelines recommend 100% of cases to<br />

be confirmed by microscopy, the above proposed algorithm<br />

was established taking into account the local context and new<br />

diagnostic tools available. We recommend all fever cases to be<br />

tested (i.e. not only suspected fever cases). As pointed out above,<br />

this will increase the number of tests performed considerably over<br />

time and will create a high workload on the health professionals<br />

at all levels of the health care system. We therefore recommend<br />

using RDTs for all fever cases. The sensitivity of these tests makes<br />

them good enough to be used as a screening tool, especially when<br />

compared to microscopy under field conditions (de Oliveira et al.,<br />

2009). In addition, RDTs have also been shown to be the most<br />

cost-effective methods to correctly diagnose malaria in a primary<br />

health care setting (Chanda et al., 2009). Massive use of RDTs<br />

will require robust systems for quality assurance (batch testing)<br />

and quality control. We suggest using PCR for quality control<br />

of all positive RDTs and a 10% sample of negative RDTs. The<br />

results of the PCR tests can also be used for the parasite strain<br />

database (see M&E section). The requirements related to the<br />

use of more complicated diagnostic methods such as PCR are<br />

discussed in the section “From ZMCP to ZMEP.”<br />

In addition to ensuring broad coverage of diagnosis, both RDTs<br />

and microscopy will need to be performed with a high degree of<br />

precision. The quality control system (see Figure 24) will need<br />

to be rigorously implemented. Fortunately the basis for such a<br />

system already exists and a budget to cover all public and private<br />

health facilities was developed for the unsuccessful health system<br />

strengthening component of the round 8 Global Fund proposal.<br />

In the proposal, the ZMCP was responsible for quality control<br />

in the public sector. The ZMCP will need to find the necessary<br />

funding–one option would be reapplying to the Global Fund–to<br />

ensure that the proposed system becomes operational as soon as<br />

possible. For the private sector, capacity development, training<br />

of private facility technicians, the development of guidelines,<br />

and supportive supervision will be done through ZAMELSO<br />

(Zanzibar Association for Medical Laboratory Scientific Officers)<br />

funded through the Rapid Funding Envelope and PACT<br />

Tanzania. It will be important regularly evaluate the system and<br />

to guarantee sustainable resources for this activity.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!